A new fused N‐heterocyclic framework, dipyrazolo‐1,3,5‐triazinane, was synthesized and the physiochemical properties of its derivatives were investigated to evaluate the integrated energetic performance. In contrast to 1,3,5‐trinitro‐1,3,5‐triazinane (RDX) featuring a distorted chair confirmation, polynitro‐functionalized dipyrazolo‐1,3,5‐triazinanes have nearly planar backbones, thereby enhancing the density and thermal stability. Among these new energetic tricyclic compounds, 5 a and 12 show favorable crystal densities of 1.937 g cm −3 and 1.990 g cm −3 at 150 K, respectively, which rank highest in triazinane‐based energetic compounds. Additionally, this synthetic approach was carried out to form seven‐membered and eight‐membered rings, giving rise to tetranitro dipyrazolo‐1,3,5‐triazepane ( 5 b ) and tetranitro dipyrazolo‐1,3,5‐triazocane ( 5 c ), respectively.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: